Download: Fast Tracking Orphan Drugs Ebook Series

In Regulation & Government, Reports by Yolanda King

Download: Orphan Drugs Ebook Series. Fast Tracking Orphan Drugs

In March 2014 the UK Early Access to Medicines Scheme (EAMS) was launched, and within two weeks an Adaptive Licencing pilot scheme (AL) was also launched by the European Medicines Agency (EMA). These two programs present new opportunities to enable drugs earlier access to market, giving patients with rare diseases quicker access to potentially life saving drugs.

We asked similar questions on these topics to notable figures within the industry and collated their views into the ebooks below, sharing their opinion on whether EAMS and AL are positive moves and what the UK can do to further orphan drugs access to market.

Hear from:

Download their reports by clicking on the links above.

Topics covered:

  • Whether or not EAMS and AL are a positive step forward
  • Top 5 recommendations for moving forward
  • How the UK currently rates in comparison with other global access programs

Interested in their views why not join us for the Fast Tracking Orphan Drugs Briefing on 10th July to hear them speak on this very topic. All four senior industry experts will be sharing their opinion on these schemes and how can they shape the industry moving forward. Click here to book your place – its not too late!

Orphan blog banner NEW